Citi lifts GSK target price but keeps neutral stance after rally
Yahoo Finance·2026-02-09 12:15
Citi lifts GSK target price but keeps neutral stance after rally Proactive uses images sourced from Shutterstock Citi has raised its price target for GSK PLC (LSE:GSK, NYSE:GSK) to £22.50 while maintaining a 'neutral' rating, citing a sharp rally driven by improving investor sentiment. The broker said full-year 2025 earnings per share were 2% ahead of consensus, with constant exchange rate guidance for 2026 broadly in line with expectations. Citi trimmed its 2026 and 2027 earnings forecasts by 1% to 2% ...